TD Asset Management Inc. Has $21.08 Million Stake in Monsanto Company (MON)
TD Asset Management Inc. lowered its stake in Monsanto Company (NYSE:MON) by 6.4% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 178,098 shares of the basic materials company’s stock after selling 12,240 shares during the period. TD Asset Management Inc.’s holdings in Monsanto were worth $21,080,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. Acrospire Investment Management LLC purchased a new position in Monsanto during the first quarter valued at about $113,000. JNBA Financial Advisors boosted its position in Monsanto by 3.9% in the first quarter. JNBA Financial Advisors now owns 1,193 shares of the basic materials company’s stock valued at $135,000 after buying an additional 45 shares in the last quarter. Penserra Capital Management LLC boosted its position in Monsanto by 9.5% in the first quarter. Penserra Capital Management LLC now owns 1,288 shares of the basic materials company’s stock valued at $145,000 after buying an additional 112 shares in the last quarter. First Bank & Trust boosted its position in Monsanto by 3.1% in the first quarter. First Bank & Trust now owns 1,361 shares of the basic materials company’s stock valued at $154,000 after buying an additional 41 shares in the last quarter. Finally, Enterprise Financial Services Corp boosted its position in Monsanto by 1.2% in the second quarter. Enterprise Financial Services Corp now owns 1,384 shares of the basic materials company’s stock valued at $164,000 after buying an additional 16 shares in the last quarter. 75.28% of the stock is owned by hedge funds and other institutional investors.
Shares of Monsanto Company (MON) opened at 116.77 on Thursday. Monsanto Company has a 12 month low of $97.35 and a 12 month high of $118.97. The firm has a market cap of $51.30 billion, a price-to-earnings ratio of 25.22 and a beta of 1.07. The company’s 50-day moving average is $117.29 and its 200-day moving average is $115.58.
Monsanto (NYSE:MON) last announced its earnings results on Wednesday, June 28th. The basic materials company reported $1.93 EPS for the quarter, topping the consensus estimate of $1.74 by $0.19. The firm had revenue of $4.23 billion for the quarter, compared to the consensus estimate of $4.18 billion. Monsanto had a net margin of 14.11% and a return on equity of 45.26%. The business’s quarterly revenue was up 1.0% on a year-over-year basis. During the same period last year, the company posted $2.17 EPS. On average, equities research analysts forecast that Monsanto Company will post $4.89 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, October 6th will be issued a dividend of $0.54 per share. The ex-dividend date of this dividend is Thursday, October 5th. This represents a $2.16 annualized dividend and a yield of 1.85%. Monsanto’s dividend payout ratio (DPR) is currently 46.75%.
WARNING: This article was published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this article on another domain, it was illegally stolen and republished in violation of United States & international copyright legislation. The original version of this article can be read at https://www.thecerbatgem.com/2017/08/24/td-asset-management-inc-has-21-08-million-stake-in-monsanto-company-mon.html.
Several research analysts recently issued reports on the stock. UBS AG cut shares of Monsanto from a “positive” rating to a “neutral” rating in a report on Tuesday, June 27th. Piper Jaffray Companies set a $128.00 price target on shares of Monsanto and gave the stock a “buy” rating in a report on Friday, August 11th. Royal Bank Of Canada reissued a “hold” rating and set a $128.00 price target on shares of Monsanto in a report on Wednesday, August 2nd. Jefferies Group LLC cut shares of Monsanto from a “buy” rating to a “hold” rating and set a $128.00 price target for the company. in a report on Wednesday, July 12th. Finally, Barclays PLC increased their target price on shares of Monsanto from $115.00 to $120.00 and gave the company an “equal weight” rating in a report on Thursday, June 29th. One investment analyst has rated the stock with a sell rating, twelve have issued a hold rating and eight have given a buy rating to the stock. Monsanto has a consensus rating of “Hold” and an average target price of $123.43.
In other Monsanto news, EVP Robert T. Fraley sold 52,410 shares of the firm’s stock in a transaction that occurred on Monday, July 10th. The shares were sold at an average price of $117.95, for a total transaction of $6,181,759.50. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Janet M. Holloway sold 3,337 shares of the firm’s stock in a transaction that occurred on Friday, June 2nd. The stock was sold at an average price of $118.00, for a total transaction of $393,766.00. Following the sale, the senior vice president now owns 44,405 shares in the company, valued at $5,239,790. The disclosure for this sale can be found here. Insiders have sold a total of 74,470 shares of company stock worth $8,791,281 over the last 90 days. Corporate insiders own 0.79% of the company’s stock.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).
Receive News & Stock Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related stocks with our FREE daily email newsletter.